Gilead Sciences plans to acquire Ouro Medicines for up to about $2.18 billion and develop the assets from the deal in a ...

Discover the heartwarming story of 158 giant tortoises returning to their ancestral home on Floreana Island after nearly two ...

New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos Following this transaction, the Company ...

Galapagos (NASDAQ:GLPG) said it has entered into a binding collaboration agreement with Gilead focused on Gamgertamig, a BCMA ...

Gilead Sciences is paying $1.67 billion for a T-cell engager (TCE) company via a front-loaded deal that could also give new ...

The pinnacle of this journey toward greater sustainability is the addition of a new vessel to the Golden Galapagos fleet.

Galapagos NV (NASDAQ:GLPG) is one of the 7 Fastest Growing European Stocks to Invest In. On March 31, 2026, Galapagos NV ...

Almost 200 years after Charles Darwin’s groundbreaking trip to the Galápagos islands, a graduate student from San Francisco ...

Gilead Sciences (NasdaqGS:GILD) has entered a definitive agreement to acquire Ouro Medicines, expanding into T cell engager ...

The Galapagos can be an overwhelming experience for clients, albeit the experience of a lifetime. And having that opportunity with luxury operator Ecoventura aboard a Relais & Chateaux megayacht can ...

Galapagos (GLPG) backs Gilead’s Ouro Medicines deal, sharing $1.675B upfront and milestones, plus 20–23% royalties on gamgertamig—read more.

Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro MedicinesNew partnership structure ...